Oraverse

Product manufactured by Septodont, Inc.

Application Nr Approved Date Route Status External Links
NDA022159 None Submucosal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1. Indicatons And Usage Oraverse An Alpha Adrenergic Blocker, Is Indicated For Adult And Pediatric Patients Ages 3 Years And Older For The Reversal Of Soft-Tissue Anesthesia, I.e., Anesthesia Of The Lip And Tongue, And The Associated Functional Deficits Resulting From An Intraoral Submucosal Injection Of A Local Anesthetic Containing A Vasoconstrictor. Oraverse, An Alpha Adrenergic Blocker, Is Indicated For Adult And Pediatric Patients Ages 3 Years And Older For The Reversal Of Soft-Tissue Anesthesia, I.e., Anesthesia Of The Lip And Tongue, And The Associated Functional Deficits Resulting From An Intraoral Submucosal Injection Of A Local Anesthetic Containing A Vasoconstrictor. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Phentolamine Mesylate PHENTOLAMINE MESYLATE ZINC20251

Comments